A course designed to equip individuals implementing GCLP within laboratories handling samples from clinical trials
More informationJoin the community - networking, discussion and more. Open to all.
More informationCould you write an interesting article for the RQA community?
More informationThe EU Commission published a new notice in the Official Journal of the EU on 25 January 2021 entitled "Application of the Union’s pharmaceutical acquis in markets historically dependent on medicines supply from or through Great Britain after the end of the transition period 2021/C 27/08)".
European Health Emergency Preparedness and Response Authority (HERA) - New health authority
Pharmacovigilance requirements for UK authorised products webinar recording, which took place on 13 January 2020. This webinar was part of a series of Brexit and post-transition guidance webinars.
An interesting article by the NHS HRA - Public involvement in a pandemic: lessons from the UK COVID-19 public involvement matching service.
New podcast series looks at innovation in trial design and study delivery during the COVID pandemic
HRA are launching HRA Now - a new way to share the changes that researchers and R&D professionals need to know about.
EMA has published an overview of its key recommendations in 2020 on the authorisation and safety monitoring of medicines for human and veterinary use.
CVMP adopts its workplan for 2021 and its strategy on antimicrobials for 2021-2025 CVMP opinions on veterinary medicinal products
The European Medicines Agency, EMA, is still planning with December 2021 for the go-live date of the EU Clinical Trials Information System (CTIS) database and portal, and thus with the first application of the Clinical Trial Regulation (CTR, Regulation (EU) No 536/2014).
Janet Woodcock was named Acting Commissioner of Food and Drugs on January 20, 2021.